Zusammenfassung
Nach Verletzung der Gefäßwand durch Makro- oder Mikrotraumata führt ein gerichtetes Zusammenspiel aus Endothelzellen, Thrombozyten, Leukozyten, Gerinnungsfaktoren, Gerinnungsinhibitoren und Fibrinolysefaktoren zur Blutstillung und Reparatur der Verletzung.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
van den Belt AGM, Prins MR, Huisman MV, Hirsh J (1996) Familial Thrombophilia: a Review Analysis. Clin Appl Thrombosis/Hemostasis 2(4): 227–236
Bertina RM, Koehleman BPC, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64–67
van der Born JG, Bots M, Haverkate F et al. (1996) Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 125: 265–269
van Boven HH, Poort SR, Bertina RM, Rosendaal FR (1997) Contribution of additional genetic risk factors in symptomatic antithrombin deficient individuals: FV 1691 A and F II 20210 A. Abstracts XVIth Congr. of the Int. Society on Thrombosis and Haemostasis, Florence, Italy, June 6–12, 1997. Thrombosis and Haemostasis Suppl 379
Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90: 1004–1008
Dahlbäck B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91: 1396–1400
Griffin JH, Evatt BL, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 32: 1989–1993
Halbmayer WM, Haushofer A, Schön R, Fischer M (1994) The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinol 5: 51–57
den Heijer M, Koster T, Blom HJ, Bos GM J, Briet E, Reitsma PH, Vandenbrougke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334/12: 759–762
Heimpel H, Hoelzer D, Lohmann HP, Scifried E (1996) Hämatologie in der Praxis. Gustav Fischer Verlag, Jena Stuttgart
Hillarp A, Dahlbäck B (1997) Activated protein C resistance. Vessels 3: 1,4–10
Kirchmaier CM, Schirmer A, Jablonka B, Meyer M, Just M, Breddin HK (1993) Prediction of bleeding risk in Glanzmann’s Thrombasthenia. Thromb Haemostas 69 (6): 921
Koster T, Rosendaal FR, de Ronde F, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet 342: 1503–1506
Lensen RPM, Rosendaal FR (1997) Factor V Leiden. Vessels 3: 11–15
Pötzsch B, Hund S, Müller-Berghaus G (1997) Dysfunctional thrombin: a new type of inherited thrombophilia? Abstracts XVIth Congr. of the Int. Society on Thrombosis and Haemostasis, Florence, Italy, June 6–12, 1997. Thrombosis and Haemostasis Suppl 180
Scifried E (1996) Erkrankungen des Gerinnungssystems. In: Classen M, Dierkesmann R, Heimpel H, Kalden JR, Koch KM, Meyer J, Spengel FA, Ziegler R (Hrsg) Rationelle Diagnostik und Therapie in der Inneren Medizin. Urban & Schwarzenberg Verlag.
Seligsohn U, Zivelin A (1997) Thrombophilia as a Multigenic Disorder. Thrombosis and Haemostasis 78(1): 297–301
Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330: 517–521
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Seifried, E. (1997). Physiologische Aspekte der Gerinnungshemmung. In: Völler, H. (eds) Gerinnungsmanagement kardiovaskulärer Erkrankungen. Steinkopff. https://doi.org/10.1007/978-3-642-48052-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-48052-2_1
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1092-0
Online ISBN: 978-3-642-48052-2
eBook Packages: Springer Book Archive